Globe Life (GL) Financials

$121.16 +1.66 (+1.39%)

Closing price 04/14/2025 03:58 PM Eastern

Extended Trading

$118.28 -2.88 (-2.38%)

As of 07:15 AM Eastern

Annual Income Statements for Globe Life

This table shows Globe Life's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	527	550	1,454	701	761	732	1,031	894	971	1,071
Consolidated Net Income / (Loss)	527	550	1,454	701	761	732	1,031	894	971	1,071
Net Income / (Loss) Continuing Operations	516	540	1,458	702	761	732	1,031	894	971	1,071
Total Pre-Tax Income	766	772	831	864	931	897	1,275	1,102	1,194	1,327
Total Operating Income	2,217	856	-2,368	954	1,016	983	1,358	1,193	1,297	1,454
Total Gross Profit	3,124	1,806	-1,355	2,029	2,170	2,165	2,453	2,401	2,583	2,884
Total Revenue	3,766	3,935	873	4,304	4,528	4,738	5,112	5,227	5,448	5,778
Operating Revenue	3,766	3,935	871	4,304	4,528	4,738	5,112	5,227	5,448	5,778
Total Cost of Revenue	642	2,129	2,228	2,275	2,357	2,573	2,659	2,825	2,864	2,894
Operating Cost of Revenue	642	2,129	2,228	2,275	2,357	2,573	2,659	2,825	2,864	2,894
Total Operating Expenses	907	950	1,013	1,075	1,155	1,182	1,095	1,209	1,287	1,430
Selling, General & Admin Expense	224	232	257	280	305	301	322	354	348	419
Amortization Expense	446	469	490	517	552	576	318	349	380	410
Other Operating Expenses / (Income)	238	249	265	278	298	305	455	506	559	601
Total Other Income / (Expense), net	-1,451	-83	3,198	-90	-84	-87	-83	-90	-102	-127
Interest Expense	77	83	85	90	84	87	83	90	102	127
Income Tax Expense	250	233	-628	162	170	165	243	208	224	256
Basic Earnings per Share	$4.21	$4.58	$12.50	$6.22	$6.97	$6.90	$10.10	$9.13	$10.21	$11.99
Weighted Average Basic Shares Outstanding	121.26M	117.76M	114.08M	110.24M	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Diluted Earnings per Share	$4.16	$4.49	$12.22	$6.09	$6.83	$6.82	$9.99	$9.04	$10.07	$11.94
Weighted Average Diluted Shares Outstanding	121.26M	117.76M	114.08M	110.24M	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Weighted Average Basic & Diluted Shares Outstanding	121.26M	117.76M	114.08M	110.24M	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Cash Dividends to Common per Share	$0.54	$0.56	$0.60	$0.64	$0.69	$0.75	$0.79	$0.83	$0.90	$0.96

This table shows Globe Life's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	191	242	224	215	257	275	254	258	303	255
Consolidated Net Income / (Loss)	191	242	224	215	257	275	254	258	303	255
Net Income / (Loss) Continuing Operations	191	242	224	215	257	275	254	258	303	255
Total Pre-Tax Income	235	297	274	265	319	337	315	322	377	312
Total Operating Income	-821	1,401	299	290	345	362	344	354	408	348
Total Gross Profit	-520	1,712	613	609	665	696	684	705	767	728
Total Revenue	218	2,414	1,321	1,326	1,384	1,416	1,416	1,440	1,455	1,466
Operating Revenue	218	2,415	1,321	1,326	1,384	1,416	1,416	1,440	1,455	1,466
Total Cost of Revenue	738	702	708	718	719	720	732	736	688	739
Operating Cost of Revenue	738	702	708	718	719	720	732	736	688	739
Total Operating Expenses	301	311	314	319	320	334	341	351	359	379
Selling, General & Admin Expense	88	92	84	86	86	92	93	99	105	122
Amortization Expense	88	90	92	94	96	98	99	102	104	104
Other Operating Expenses / (Income)	125	130	138	138	139	144	148	150	150	153
Total Other Income / (Expense), net	1,055	-1,104	-25	-26	-26	-26	-29	-31	-31	-36
Interest Expense	24	25	25	26	26	26	29	31	31	36
Income Tax Expense	44	54	51	49	62	62	61	64	74	57
Basic Earnings per Share	$1.96	$2.50	$2.32	$2.26	$2.72	$2.91	$2.71	$2.83	$3.45	$3.00
Weighted Average Basic Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M
Diluted Earnings per Share	$1.94	$2.47	$2.28	$2.24	$2.68	$2.87	$2.67	$2.83	$3.44	$3.00
Weighted Average Diluted Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M
Weighted Average Basic & Diluted Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M

This table details how cash moves in and out of Globe Life's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-4.64	15	48	-10	-45	19	-2.68	0.40	11	62
Net Cash From Operating Activities	1,120	1,399	1,429	1,278	1,364	1,476	1,438	1,422	1,482	1,402
Net Cash From Continuing Operating Activities	1,122	1,227	1,351	1,276	1,347	1,476	1,469	1,455	1,526	1,457
Net Income / (Loss) Continuing Operations	516	540	1,458	702	761	732	1,031	894	971	1,071
Consolidated Net Income / (Loss)	527	550	1,454	701	761	732	1,031	894	971	1,071
Amortization Expense	446	469	490	517	552	576	318	349	380	410
Non-Cash Adjustments To Reconcile Net Income	-589	41	72	-28	-712	47	-59	84	69	-121
Changes in Operating Assets and Liabilities, net	749	177	-669	87	746	122	180	127	107	97
Net Cash From Investing Activities	-633	-1,062	-927	-896	-809	-1,182	-913	-943	-926	-642
Net Cash From Continuing Investing Activities	-633	-1,062	-927	-896	-814	-1,182	-945	-976	-970	-696
Purchase of Property, Plant & Equipment	-37	-25	-20	-45	-42	-42	-38	-28	-50	-71
Purchase of Investments	-1,103	-1,568	-110	-1,185	-1,692	-1,567	-1,316	-1,780	-1,915	-2,044
Sale and/or Maturity of Investments	568	578	560	376	919	442	471	858	1,037	1,462
Other Investing Activities, net	-62	-48	-1,356	-42	0.03	-16	-62	-25	-42	-43
Net Cash From Financing Activities	-526	-320	-454	-392	-591	-274	-524	-492	-541	-716
Net Cash From Continuing Financing Activities	-526	-320	-454	-392	-591	-274	-524	-492	-541	-716
Repayment of Debt	0.00	-260	-129	-357	-6.88	-427	-233	-155	-166	-379
Repurchase of Common Equity	-419	-405	-413	-422	-460	-444	-541	-455	-511	-1,002
Payment of Dividends	-67	-67	-69	-71	-74	-78	-80	-81	-84	-85
Issuance of Debt	1.98	422	186	550	-12	700	325	204	203	1,001
Issuance of Common Equity	36	61	61	36	83	48	70	107	114	52
Other Financing Activities, net	-78	-72	-91	-127	-121	-73	-64	-113	-97	-302
Effect of Exchange Rate Changes	34	-1.70	-	-	-	-1.73	-3.39	14	-4.19	17

This table details how cash moves in and out of Globe Life's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-1,149	1,069	-400	-417	-281	1,108	-566	-180	-291	1,100
Net Cash From Operating Activities	357	372	477	327	287	391	351	374	341	337
Net Cash From Continuing Operating Activities	-	1,455	-310	-370	-461	2,667	0.00	-989	-117	2,562
Net Income / (Loss) Continuing Operations	-	894	0.00	-	-	971	0.00	-	-	1,071
Non-Cash Adjustments To Reconcile Net Income	-	-	-310	-370	-461	1,210	-	-	-117	985
Net Cash From Investing Activities	-283	-252	-248	-162	-418	-98	-732	105	-196	181
Net Cash From Continuing Investing Activities	-283	-285	62	208	43	-1,283	-681	1,044	-80	-979
Purchase of Property, Plant & Equipment	-6.14	-8.16	-8.21	-17	-11	-13	-9.11	-18	-29	-15
Purchase of Investments	-489	-415	16	2.21	-91	-1,842	-763	579	-280	-1,579
Sale and/or Maturity of Investments	247	84	79	255	172	531	112	499	255	596
Other Investing Activities, net	-35	55	-25	-32	-27	42	-21	-16	-25	19
Net Cash From Financing Activities	-170	-115	-152	-255	137	-272	357	-477	-95	-501
Net Cash From Continuing Financing Activities	-170	-115	-152	-255	137	-272	115	-235	-95	-501
Repayment of Debt	-61	61	-	-	-8.76	34	5.30	-357	61	-89
Repurchase of Common Equity	-72	-119	-179	-90	-97	-145	-23	-336	-591	-52
Payment of Dividends	-20	-20	-20	-21	-21	-21	-21	-23	-22	-20
Issuance of Debt	-	-46	65	105	198	-165	-	-	415	67
Issuance of Common Equity	15	57	37	5.16	19	53	30	-	5.09	17
Other Financing Activities, net	-32	-47	-54	-62	47	-27	124	-39	37	-424

This table presents Globe Life's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	19,853	21,436	23,475	23,096	25,977	29,047	29,768	25,987	28,051	29,076
Total Current Assets	671	16,002	871	536	518	926	900	17,559	733	18,367
Cash & Equivalents	61	76	119	121	76	95	92	93	103	165
Short-Term Investments	265	15,541	361	-	-	357	320	16,877	-	17,510
Accounts Receivable	345	384	392	415	442	474	487	589	630	692
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	19,183	5,434	22,604	22,560	25,460	28,121	28,868	8,428	27,318	10,709
Long-Term Investments	14,289	562	17,607	17,119	19,847	22,345	22,689	1,591	19,445	2,332
Goodwill	442	442	442	442	442	442	482	482	482	490
Other Noncurrent Operating Assets	4,139	4,431	4,487	4,931	5,171	5,334	5,697	6,355	7,112	7,887
Total Liabilities & Shareholders' Equity	19,853	21,436	23,475	37,559	25,977	29,047	29,768	25,987	28,051	29,076
Total Liabilities	15,798	16,869	17,244	32,144	18,683	20,276	21,125	22,037	23,565	23,771
Total Current Liabilities	2,377	2,496	2,132	1,865	2,301	2,648	2,822	1,770	1,987	2,406
Short-Term Debt	490	264	328	308	299	255	480	449	486	415
Current Deferred Revenue	67	64	61	-	64	62	65	253	255	258
Current Deferred & Payable Income Tax Liabilities	1,451	1,744	1,312	1,048	1,477	1,834	1,765	435	495	731
Other Current Liabilities	369	97	431	509	462	497	512	633	752	1,001
Total Noncurrent Liabilities	13,421	14,373	15,111	30,279	16,382	17,628	18,303	20,268	21,578	21,365
Long-Term Debt	744	1,133	1,132	1,357	1,349	1,668	1,546	1,628	1,630	2,324
Other Noncurrent Operating Liabilities	12,626	13,240	13,929	28,870	15,033	15,960	16,757	18,640	19,948	19,041
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,056	4,567	6,231	5,415	7,294	8,771	8,643	3,950	4,487	5,306
Total Preferred & Common Equity	4,056	4,567	6,231	5,415	7,294	8,771	8,643	3,950	4,487	5,306
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,056	4,567	6,231	5,415	7,294	8,771	8,643	3,950	4,487	5,306
Common Stock	613	618	633	646	649	641	630	635	635	625
Retained Earnings	3,614	3,891	4,806	5,213	5,551	5,874	6,182	6,895	7,479	8,003
Treasury Stock	-403	-519	-632	-763	-751	-773	-847	-790	-854	-1,292
Accumulated Other Comprehensive Income / (Loss)	232	578	1,424	319	1,845	3,029	2,678	-2,790	-2,772	-2,030

This table presents Globe Life's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	24,839	25,987	26,860	26,708	26,166	28,051	28,571	28,299	29,557	29,076
Total Current Assets	916	17,559	18,327	18,049	17,331	733	19,232	18,724	19,506	18,367
Cash & Equivalents	86	93	172	75	86	103	84	88	135	165
Short-Term Investments	355	16,877	17,561	17,372	16,629	-	18,502	17,988	18,720	17,510
Accounts Receivable	475	589	594	602	617	630	646	648	652	692
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	23,923	8,428	8,533	8,659	8,835	27,318	9,339	9,575	10,050	10,709
Long-Term Investments	17,518	1,591	1,645	1,644	1,695	19,445	1,893	1,994	2,294	2,332
Goodwill	482	482	482	482	482	482	482	482	490	490
Other Noncurrent Operating Assets	5,923	6,355	6,406	6,533	6,659	7,112	6,964	7,099	7,266	7,887
Total Liabilities & Shareholders' Equity	24,839	25,987	26,860	26,708	26,166	28,051	28,571	28,299	29,557	29,076
Total Liabilities	20,477	22,037	23,014	22,728	21,543	23,565	23,531	23,071	24,918	23,771
Total Current Liabilities	1,588	1,770	1,845	1,628	1,985	1,987	2,555	2,536	2,322	2,406
Short-Term Debt	435	449	514	258	448	486	734	655	437	415
Current Deferred Revenue	64	253	272	267	261	255	270	270	265	258
Current Deferred & Payable Income Tax Liabilities	568	435	428	404	555	495	630	685	620	731
Other Current Liabilities	521	633	632	699	721	752	921	927	1,000	1,001
Total Noncurrent Liabilities	18,889	20,268	21,168	21,099	19,558	21,578	20,976	20,535	22,596	21,365
Long-Term Debt	1,628	1,628	1,628	1,798	1,799	1,630	1,630	1,630	2,324	2,324
Other Noncurrent Operating Liabilities	17,262	18,640	19,540	19,301	17,760	19,948	19,346	18,905	20,273	19,041
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,362	3,950	3,846	3,980	4,623	4,487	5,039	5,228	4,639	5,306
Total Preferred & Common Equity	4,362	3,950	3,846	3,980	4,623	4,487	5,039	5,228	4,639	5,306
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,362	3,950	3,846	3,980	4,623	4,487	5,039	5,228	4,639	5,306
Common Stock	650	635	634	641	649	635	629	636	645	625
Retained Earnings	6,633	6,895	7,093	7,286	7,520	7,479	7,707	7,943	8,225	8,003
Treasury Stock	-1,110	-790	-919	-	-1,087	-854	-829	-1,162	-1,747	-1,292
Accumulated Other Comprehensive Income / (Loss)	-1,812	-2,790	-2,961	-2,944	-2,459	-2,772	-2,467	-2,190	-2,485	-2,030

This table displays calculated financial ratios and metrics derived from Globe Life's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.03%	4.48%	-77.82%	393.19%	5.20%	4.65%	7.90%	2.24%	4.22%	6.07%
EBITDA Growth	3.29%	-50.26%	6.11%	4.61%	6.59%	-0.52%	7.48%	-8.02%	8.76%	11.18%
EBIT Growth	2.55%	-61.42%	6.97%	4.21%	6.48%	-3.17%	38.10%	-12.19%	8.73%	12.12%
NOPAT Growth	2.68%	-59.99%	-795.31%	118.64%	7.11%	-3.28%	36.90%	-11.92%	8.91%	11.33%
Net Income Growth	-2.92%	4.30%	164.56%	-51.77%	8.46%	-3.81%	40.91%	-13.26%	8.54%	10.30%
EPS Growth	1.71%	7.93%	172.16%	-50.16%	12.15%	-0.15%	46.48%	-9.51%	11.39%	18.57%
Operating Cash Flow Growth	29.53%	24.88%	2.17%	-10.60%	6.75%	8.25%	-2.62%	-1.08%	4.24%	-5.40%
Free Cash Flow Firm Growth	-37.11%	-19.98%	-428.20%	481.67%	-185.52%	115.00%	-25.75%	-25.16%	37.08%	-87.08%
Invested Capital Growth	-0.02%	-6.26%	-2.22%	-136.62%	55.43%	-10.21%	-2.73%	-0.82%	-3.28%	7.60%
Revenue Q/Q Growth	25.47%	-19.71%	-75.26%	325.29%	27.20%	30.61%	-26.55%	27.18%	-15.49%	0.88%
EBITDA Q/Q Growth	14.99%	-49.18%	136.57%	215.90%	93.48%	2,707.81%	-52.71%	251.11%	-38.08%	-0.40%
EBIT Q/Q Growth	18.01%	-60.06%	750.63%	153.67%	246.20%	256.11%	-53.89%	4,002.61%	-44.47%	-0.97%
NOPAT Q/Q Growth	18.21%	-59.64%	-5,594.37%	143.60%	182.85%	227.40%	-54.31%	4,003.38%	-44.47%	-0.97%
Net Income Q/Q Growth	-2.55%	0.46%	158.53%	-56.20%	44.03%	-17.53%	33.69%	7.76%	3.46%	-1.80%
EPS Q/Q Growth	-1.65%	0.90%	161.11%	0.00%	0.00%	0.00%	35.37%	8.52%	4.14%	1.10%
Operating Cash Flow Q/Q Growth	-29.76%	2.69%	-5.52%	-0.22%	-2.38%	0.00%	-1.38%	-0.41%	1.34%	-3.74%
Free Cash Flow Firm Q/Q Growth	10.20%	-51.12%	-580.61%	725.19%	-1,585.78%	5,406.58%	-52.43%	289.77%	-22.98%	-94.42%
Invested Capital Q/Q Growth	-3.42%	0.51%	5.17%	-137.86%	-0.47%	-5.03%	-2.57%	-8.66%	-12.18%	13.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.96%	45.90%	-155.30%	47.13%	47.93%	45.70%	47.98%	45.94%	47.42%	49.91%
EBITDA Margin	70.71%	33.67%	161.07%	34.17%	34.62%	32.91%	32.78%	29.49%	30.77%	32.26%
Operating Margin	58.88%	21.74%	-271.33%	22.16%	22.43%	20.76%	26.57%	22.82%	23.80%	25.16%
EBIT Margin	58.88%	21.74%	104.88%	22.16%	22.43%	20.76%	26.57%	22.82%	23.80%	25.16%
Profit (Net Income) Margin	14.00%	13.97%	166.68%	16.30%	16.80%	15.45%	20.17%	17.11%	17.82%	18.53%
Tax Burden Percent	68.80%	71.19%	175.10%	81.22%	81.69%	81.61%	80.90%	81.15%	81.28%	80.71%
Interest Burden Percent	34.55%	90.26%	90.76%	90.56%	91.70%	91.18%	93.85%	92.42%	92.11%	91.26%
Effective Tax Rate	32.62%	30.13%	-75.56%	18.78%	18.30%	18.39%	19.10%	18.85%	18.72%	19.29%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	12.04%	12.75%	26.94%	12.05%	11.97%	9.11%	11.84%	14.21%	23.01%	21.87%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	11.05%	4.14%	4.08%	4.10%	4.14%	3.57%	4.62%	4.28%	4.80%	5.09%
Return on Assets (ROA)	2.63%	2.66%	6.48%	3.01%	3.10%	2.66%	3.51%	3.21%	3.59%	3.75%
Return on Common Equity (ROCE)	12.04%	12.75%	26.94%	12.05%	11.97%	9.11%	11.84%	14.21%	23.01%	21.87%
Return on Equity Simple (ROE_SIMPLE)	13.00%	12.04%	23.34%	12.95%	10.43%	8.34%	11.93%	22.65%	21.64%	20.18%
Net Operating Profit after Tax (NOPAT)	1,494	598	-4,157	775	830	803	1,099	968	1,054	1,173
NOPAT Margin	39.68%	15.19%	-476.34%	18.00%	18.33%	16.94%	21.49%	18.52%	19.35%	20.31%
Net Nonoperating Expense Percent (NNEP)	-6.93%	-0.34%	35.74%	-0.31%	-0.29%	-0.36%	-0.32%	-0.39%	-0.49%	-0.59%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	16.06%	15.96%	14.58%
Cost of Revenue to Revenue	17.04%	54.10%	255.30%	52.87%	52.07%	54.30%	52.02%	54.06%	52.58%	50.09%
SG&A Expenses to Revenue	5.94%	5.90%	29.48%	6.50%	6.73%	6.35%	6.30%	6.77%	6.39%	7.25%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.08%	24.15%	116.03%	24.97%	25.50%	24.94%	21.42%	23.13%	23.62%	24.75%
Earnings before Interest and Taxes (EBIT)	2,217	856	915	954	1,016	983	1,358	1,193	1,297	1,454
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,663	1,325	1,406	1,470	1,567	1,559	1,676	1,541	1,676	1,864
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.62	1.81	1.60	1.47	1.51	1.10	1.08	2.91	2.52	1.76
Price to Tangible Book Value (P/TBV)	1.82	2.00	1.72	1.60	1.61	1.16	1.14	3.32	2.83	1.94
Price to Revenue (P/Rev)	1.75	2.10	11.41	1.85	2.43	2.04	1.82	2.20	2.08	1.62
Price to Earnings (P/E)	12.49	15.01	6.84	11.35	14.46	13.23	9.02	12.86	11.67	8.72
Dividend Yield	1.00%	0.80%	0.68%	0.88%	0.67%	0.79%	0.85%	0.69%	0.73%	0.85%
Earnings Yield	8.00%	6.66%	14.61%	8.81%	6.92%	7.56%	11.09%	7.78%	8.57%	11.46%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.30	0.31	0.23	0.31	0.23	0.22	0.23	0.53	0.47	0.52
Long-Term Debt to Equity	0.18	0.25	0.18	0.25	0.18	0.19	0.18	0.41	0.36	0.44
Financial Leverage	-3.19	-3.29	-2.91	-4.01	-3.80	-2.44	-2.41	-2.98	-4.02	-3.54
Leverage Ratio	4.58	4.79	4.16	4.00	3.86	3.43	3.38	4.43	6.41	5.83
Compound Leverage Factor	1.58	4.32	3.77	3.62	3.54	3.12	3.17	4.09	5.90	5.32
Debt to Total Capital	23.33%	23.43%	18.99%	23.52%	18.43%	17.98%	18.99%	34.46%	32.04%	34.05%
Short-Term Debt to Total Capital	9.27%	4.43%	4.27%	4.35%	3.34%	2.38%	4.50%	7.45%	7.36%	5.16%
Long-Term Debt to Total Capital	14.06%	19.00%	14.72%	19.17%	15.09%	15.60%	14.50%	27.01%	24.68%	28.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	76.67%	76.57%	81.02%	76.48%	81.57%	82.02%	81.01%	65.54%	67.96%	65.95%
Debt to EBITDA	0.46	1.06	1.04	1.13	1.05	1.23	1.21	1.35	1.26	1.47
Net Debt to EBITDA	-5.02	-11.16	-11.83	-10.59	-11.66	-13.39	-12.58	-10.69	-10.40	-9.26
Long-Term Debt to EBITDA	0.28	0.86	0.81	0.92	0.86	1.07	0.92	1.06	0.97	1.25
Debt to NOPAT	0.83	2.34	-0.35	2.15	1.99	2.40	1.84	2.15	2.01	2.33
Net Debt to NOPAT	-8.96	-24.73	4.00	-20.10	-22.03	-26.01	-19.18	-17.03	-16.54	-14.72
Long-Term Debt to NOPAT	0.50	1.90	-0.27	1.75	1.63	2.08	1.41	1.68	1.55	1.98
Altman Z-Score	0.96	1.62	0.73	0.72	0.87	0.77	0.80	1.77	0.95	1.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.28	6.41	0.41	0.29	0.22	0.35	0.32	9.92	0.37	7.63
Quick Ratio	0.28	6.41	0.41	0.29	0.22	0.35	0.32	9.92	0.37	7.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,497	1,198	-3,930	15,001	-12,829	1,924	1,429	1,069	1,466	189
Operating Cash Flow to CapEx	3,030.68%	5,578.77%	7,051.16%	2,833.42%	3,231.70%	3,535.86%	3,759.23%	5,092.18%	2,991.59%	1,974.02%
Free Cash Flow to Firm to Interest Expense	19.53	14.37	-46.50	166.54	-152.17	22.19	17.11	11.83	14.32	1.49
Operating Cash Flow to Interest Expense	14.61	16.78	16.91	14.18	16.18	17.03	17.22	15.73	14.49	11.03
Operating Cash Flow Less CapEx to Interest Expense	14.13	16.48	16.67	13.68	15.68	16.55	16.76	15.42	14.00	10.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.19	0.19	0.04	0.18	0.18	0.17	0.17	0.19	0.20	0.20
Accounts Receivable Turnover	11.20	10.79	2.25	10.67	10.57	10.35	10.63	9.71	8.93	8.74
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	32.58	33.81	162.34	34.22	34.54	35.28	34.33	37.59	40.85	41.76
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	32.58	33.81	162.34	34.22	34.54	35.28	34.33	37.59	40.85	41.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-9,587	-10,187	-10,413	-24,640	-10,981	-12,103	-12,433	-12,534	-12,946	-11,962
Invested Capital Turnover	-0.39	-0.40	-0.08	-0.25	-0.25	-0.41	-0.42	-0.42	-0.43	-0.46
Increase / (Decrease) in Invested Capital	-2.33	-600	-226	-14,227	13,659	-1,121	-330	-101	-412	984
Enterprise Value (EV)	-6,795	-6,527	-6,673	-7,615	-7,277	-11,192	-11,780	-4,981	-6,106	-7,926
Market Capitalization	6,586	8,254	9,953	7,959	10,999	9,682	9,296	11,502	11,327	9,341
Book Value per Share	$32.88	$38.49	$53.98	$48.55	$67.36	$83.80	$85.59	$40.60	$47.67	$63.20
Tangible Book Value per Share	$29.30	$34.77	$50.15	$44.59	$63.28	$79.58	$80.82	$35.65	$42.55	$57.36
Total Capital	5,289	5,965	7,692	7,080	8,942	10,694	10,669	6,027	6,602	8,045
Total Debt	1,234	1,398	1,460	1,665	1,648	1,923	2,026	2,077	2,116	2,740
Total Long-Term Debt	744	1,133	1,132	1,357	1,349	1,668	1,546	1,628	1,630	2,324
Net Debt	-13,381	-14,781	-16,626	-15,575	-18,275	-20,874	-21,075	-16,483	-17,432	-17,267
Capital Expenditures (CapEx)	37	25	20	45	42	42	38	28	50	71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,542	-1,848	-1,413	-1,142	-1,561	-1,919	-1,855	-731	-871	-1,298
Debt-free Net Working Capital (DFNWC)	-1,216	13,770	-933	-1,021	-1,485	-1,467	-1,442	16,238	-768	16,377
Net Working Capital (NWC)	-1,706	13,505	-1,262	-1,329	-1,783	-1,722	-1,922	15,789	-1,254	15,961
Net Nonoperating Expense (NNE)	967	48	-5,611	73	69	71	68	73	83	103
Net Nonoperating Obligations (NNO)	-13,643	-14,754	-16,645	-30,055	-18,275	-20,874	-21,075	-16,483	-17,432	-17,267
Total Depreciation and Amortization (D&A)	446	469	490	517	552	576	318	349	380	410
Debt-free, Cash-free Net Working Capital to Revenue	-40.95%	-46.96%	-161.88%	-26.54%	-34.47%	-40.50%	-36.29%	-13.99%	-15.99%	-22.47%
Debt-free Net Working Capital to Revenue	-32.29%	349.96%	-106.97%	-23.72%	-32.79%	-30.97%	-28.21%	310.68%	-14.09%	283.43%
Net Working Capital to Revenue	-45.31%	343.24%	-144.57%	-30.88%	-39.39%	-36.35%	-37.60%	302.08%	-23.02%	276.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$6.97	$6.90	$7.30	$7.55	$10.21	$11.99
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$6.83	$6.82	$7.22	$7.47	$10.07	$11.94
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	107.53M	103.28M	99.34M	96.50M	93.71M	83.85M
Normalized Net Operating Profit after Tax (NOPAT)	1,494	598	-1,657	775	830	803	1,099	968	1,054	1,173
Normalized NOPAT Margin	39.68%	15.19%	-189.93%	18.00%	18.33%	16.94%	21.49%	18.52%	19.35%	20.31%
Pre Tax Income Margin	20.34%	19.63%	95.19%	20.07%	20.57%	18.93%	24.93%	21.09%	21.92%	22.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	28.93	10.27	10.83	10.59	12.05	11.34	16.27	13.19	12.67	11.44
NOPAT to Interest Expense	19.50	7.17	-49.17	8.60	9.84	9.26	13.16	10.71	10.30	9.23
EBIT Less CapEx to Interest Expense	28.45	9.96	10.59	10.09	11.55	10.86	15.81	12.88	12.19	10.88
NOPAT Less CapEx to Interest Expense	19.01	6.87	-49.41	8.10	9.34	8.77	12.70	10.40	9.82	8.67
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.69%	12.17%	4.73%	10.18%	9.75%	10.69%	7.76%	9.01%	8.67%	7.98%
Augmented Payout Ratio	92.09%	85.80%	33.13%	70.31%	70.16%	71.34%	60.27%	59.84%	61.31%	101.57%

This table displays calculated financial ratios and metrics derived from Globe Life's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-82.94%	86.22%	1.43%	2.68%	535.05%	-41.36%	7.18%	8.58%	5.15%	3.57%
EBITDA Growth	-14.02%	220.98%	-1.80%	-0.02%	27.04%	-69.15%	13.18%	18.53%	16.37%	-1.63%
EBIT Growth	2.81%	133.66%	-4.78%	-2.67%	33.25%	-74.13%	14.86%	21.84%	18.44%	-3.94%
NOPAT Growth	-423.41%	138.41%	-3.82%	-2.23%	141.74%	-74.15%	13.71%	20.00%	18.06%	-3.86%
Net Income Growth	0.91%	-47.78%	-5.84%	-3.89%	34.89%	13.39%	13.69%	20.02%	17.86%	-7.13%
EPS Growth	5.43%	-45.47%	-3.80%	-0.89%	38.14%	16.19%	17.11%	26.34%	28.36%	4.53%
Operating Cash Flow Growth	-0.28%	-1.55%	20.19%	10.31%	-19.64%	5.27%	-26.51%	14.48%	18.72%	-13.92%
Free Cash Flow Firm Growth	-255.74%	53.79%	128.38%	13,795.88%	122.58%	-43.20%	-102.44%	-114.10%	796.96%	-198.91%
Invested Capital Growth	4.84%	-0.82%	-10.17%	-10.84%	-0.04%	-3.28%	2.34%	3.81%	-19.15%	7.60%
Revenue Q/Q Growth	-83.13%	1,007.75%	-45.27%	0.39%	4.35%	2.28%	0.03%	1.70%	1.05%	0.75%
EBITDA Q/Q Growth	-9.81%	329.93%	-73.74%	-1.79%	14.60%	4.40%	-3.68%	2.85%	12.51%	-11.75%
EBIT Q/Q Growth	-13.25%	441.33%	-78.65%	-2.93%	18.75%	5.11%	-5.20%	2.96%	15.44%	-14.75%
NOPAT Q/Q Growth	-375.64%	271.75%	-78.68%	-3.12%	17.67%	6.38%	-6.23%	2.24%	15.76%	-13.37%
Net Income Q/Q Growth	-14.91%	27.16%	-7.73%	-3.73%	19.43%	6.89%	-7.49%	1.63%	17.28%	-15.78%
EPS Q/Q Growth	-14.16%	27.32%	-7.69%	-1.75%	19.64%	7.09%	-6.97%	5.99%	21.55%	-12.79%
Operating Cash Flow Q/Q Growth	20.50%	4.15%	28.38%	-31.53%	-12.22%	36.43%	-10.37%	6.65%	-8.96%	-1.08%
Free Cash Flow Firm Q/Q Growth	-11,240.29%	199.39%	18.87%	2.23%	-81.30%	150.03%	-102.88%	-490.10%	1,289.25%	-127.57%
Invested Capital Q/Q Growth	2.06%	-8.66%	-6.82%	2.50%	11.60%	-12.18%	3.11%	3.96%	-9.49%	13.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	-238.41%	70.91%	46.42%	45.91%	48.05%	49.16%	48.32%	48.92%	52.72%	49.62%
EBITDA Margin	159.09%	61.75%	29.62%	28.98%	31.83%	32.49%	31.28%	31.64%	35.22%	30.85%
Operating Margin	-376.47%	58.01%	22.64%	21.89%	24.91%	25.60%	24.26%	24.56%	28.06%	23.74%
EBIT Margin	118.71%	58.01%	22.64%	21.89%	24.91%	25.60%	24.26%	24.56%	28.06%	23.74%
Profit (Net Income) Margin	87.44%	10.04%	16.92%	16.23%	18.57%	19.41%	17.95%	17.94%	20.82%	17.40%
Tax Burden Percent	81.18%	81.68%	81.54%	81.38%	80.64%	81.61%	80.72%	80.15%	80.38%	81.68%
Interest Burden Percent	90.74%	21.18%	91.69%	91.11%	92.47%	92.91%	91.67%	91.12%	92.31%	89.75%
Effective Tax Rate	18.82%	18.32%	18.46%	18.62%	19.36%	18.39%	19.28%	19.85%	19.62%	18.32%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	12.80%	14.21%	16.40%	18.74%	20.89%	23.01%	22.54%	22.69%	23.55%	21.87%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	17.96%	10.88%	4.34%	4.38%	6.30%	5.16%	4.85%	5.05%	5.77%	4.80%
Return on Assets (ROA)	13.23%	1.88%	3.25%	3.25%	4.69%	3.91%	3.59%	3.69%	4.28%	3.52%
Return on Common Equity (ROCE)	12.80%	14.21%	16.40%	18.74%	20.89%	23.01%	22.54%	22.69%	23.55%	21.87%
Return on Equity Simple (ROE_SIMPLE)	19.03%	0.00%	22.89%	21.90%	20.30%	0.00%	19.87%	19.98%	23.51%	0.00%
Net Operating Profit after Tax (NOPAT)	-666	1,144	244	236	278	296	277	284	328	284
NOPAT Margin	-305.61%	47.38%	18.46%	17.81%	20.09%	20.89%	19.58%	19.69%	22.55%	19.39%
Net Nonoperating Expense Percent (NNEP)	4.68%	-4.80%	-0.11%	-0.12%	-0.13%	-0.12%	-0.13%	-0.14%	-0.15%	-0.17%
Return On Investment Capital (ROIC_SIMPLE)	-	18.98%	-	-	-	4.48%	-	-	-	3.53%
Cost of Revenue to Revenue	338.41%	29.09%	53.58%	54.09%	51.95%	50.84%	51.68%	51.08%	47.28%	50.38%
SG&A Expenses to Revenue	40.44%	3.80%	6.37%	6.49%	6.20%	6.48%	6.58%	6.88%	7.21%	8.32%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	138.07%	12.90%	23.79%	24.02%	23.14%	23.56%	24.07%	24.36%	24.66%	25.87%
Earnings before Interest and Taxes (EBIT)	259	1,401	299	290	345	362	344	354	408	348
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	347	1,491	391	384	441	460	443	456	513	452
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.20	2.91	2.74	2.60	2.21	2.52	2.16	1.45	2.05	1.76
Price to Tangible Book Value (P/TBV)	2.47	3.32	3.13	2.96	2.46	2.83	2.39	1.60	2.29	1.94
Price to Revenue (P/Rev)	2.34	2.20	2.01	1.96	1.58	2.08	1.96	1.34	1.66	1.62
Price to Earnings (P/E)	11.57	12.86	11.96	11.88	10.86	11.67	10.87	7.25	8.70	8.72
Dividend Yield	0.82%	0.69%	0.78%	0.78%	0.80%	0.73%	0.78%	1.12%	0.88%	0.85%
Earnings Yield	8.64%	7.78%	8.36%	8.42%	9.20%	8.57%	9.20%	13.80%	11.49%	11.46%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.53	0.56	0.52	0.49	0.47	0.47	0.44	0.60	0.52
Long-Term Debt to Equity	0.37	0.41	0.42	0.45	0.39	0.36	0.32	0.31	0.50	0.44
Financial Leverage	-2.82	-2.98	-3.38	-3.67	-3.57	-4.02	-3.98	-3.78	-3.73	-3.54
Leverage Ratio	4.19	4.43	5.09	5.67	5.68	6.41	6.24	5.97	6.02	5.83
Compound Leverage Factor	3.80	0.94	4.67	5.17	5.25	5.95	5.72	5.44	5.55	5.24
Debt to Total Capital	32.10%	34.46%	35.78%	34.06%	32.70%	32.04%	31.93%	30.42%	37.31%	34.05%
Short-Term Debt to Total Capital	6.77%	7.45%	8.59%	4.28%	6.52%	7.36%	9.91%	8.71%	5.91%	5.16%
Long-Term Debt to Total Capital	25.34%	27.01%	27.19%	29.79%	26.18%	24.68%	22.02%	21.70%	31.40%	28.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.90%	65.54%	64.22%	65.94%	67.30%	67.96%	68.07%	69.59%	62.69%	65.95%
Debt to EBITDA	4.70	1.35	1.40	1.34	0.83	1.26	1.37	1.27	1.48	1.47
Net Debt to EBITDA	-36.21	-10.69	-11.23	-11.10	-5.97	-10.40	-10.48	-9.89	-9.83	-9.26
Long-Term Debt to EBITDA	3.71	1.06	1.06	1.17	0.66	0.97	0.94	0.91	1.24	1.25
Debt to NOPAT	87.44	2.15	2.24	2.16	1.18	2.01	2.17	2.01	2.33	2.33
Net Debt to NOPAT	-674.03	-17.03	-17.99	-17.88	-8.52	-16.54	-16.66	-15.67	-15.52	-14.72
Long-Term Debt to NOPAT	69.01	1.68	1.70	1.89	0.95	1.55	1.50	1.44	1.96	1.98
Altman Z-Score	0.82	1.79	1.61	1.63	1.68	0.84	1.59	1.52	1.56	1.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.58	9.92	9.93	11.09	8.73	0.37	7.53	7.38	8.40	7.63
Quick Ratio	0.58	9.92	9.93	11.09	8.73	0.37	7.53	7.38	8.40	7.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,253	1,245	1,480	1,513	283	707	-36	-213	2,538	-700
Operating Cash Flow to CapEx	5,815.23%	4,554.78%	5,814.01%	1,876.18%	2,651.45%	2,986.85%	3,852.47%	2,121.81%	1,162.07%	2,246.48%
Free Cash Flow to Firm to Interest Expense	-52.29	50.51	59.53	58.61	10.90	27.55	-1.26	-6.80	80.85	-19.61
Operating Cash Flow to Interest Expense	14.90	15.08	19.20	12.66	11.05	15.24	12.26	11.91	10.85	9.44
Operating Cash Flow Less CapEx to Interest Expense	14.64	14.75	18.87	11.98	10.64	14.73	11.94	11.35	9.92	9.02
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.15	0.19	0.19	0.20	0.25	0.20	0.20	0.21	0.21	0.20
Accounts Receivable Turnover	8.55	9.71	9.69	9.77	11.80	8.93	8.94	9.05	9.03	8.74
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	42.67	37.59	37.66	37.34	30.92	40.85	40.84	40.33	40.43	41.76
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	42.67	37.59	37.66	37.34	30.92	40.85	40.84	40.33	40.43	41.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-11,535	-12,534	-13,389	-13,054	-11,540	-12,946	-13,076	-12,557	-13,749	-11,962
Invested Capital Turnover	-0.35	-0.42	-0.41	-0.43	-0.56	-0.43	-0.42	-0.44	-0.45	-0.46
Increase / (Decrease) in Invested Capital	587	-101	-1,236	-1,277	-4.92	-412	313	497	-2,210	984
Enterprise Value (EV)	-6,295	-4,981	-6,705	-6,675	-5,969	-6,106	-7,234	-10,215	-8,897	-7,926
Market Capitalization	9,602	11,502	10,531	10,360	10,194	11,327	10,881	7,570	9,491	9,341
Book Value per Share	$44.76	$40.60	$39.86	$41.65	$48.76	$47.67	$53.78	$56.66	$51.64	$63.20
Tangible Book Value per Share	$39.82	$35.65	$34.87	$36.61	$43.68	$42.55	$48.63	$51.44	$46.18	$57.36
Total Capital	6,424	6,027	5,989	6,037	6,869	6,602	7,403	7,513	7,400	8,045
Total Debt	2,062	2,077	2,143	2,056	2,246	2,116	2,364	2,285	2,761	2,740
Total Long-Term Debt	1,628	1,628	1,628	1,798	1,799	1,630	1,630	1,630	2,324	2,324
Net Debt	-15,896	-16,483	-17,236	-17,035	-16,163	-17,432	-18,115	-17,785	-18,388	-17,267
Capital Expenditures (CapEx)	6.14	8.16	8.21	17	11	13	9.11	18	29	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-678	-731	-737	-768	-920	-871	-1,176	-1,233	-1,232	-1,298
Debt-free Net Working Capital (DFNWC)	-237	16,238	16,996	16,679	15,794	-768	17,410	16,843	17,622	16,377
Net Working Capital (NWC)	-672	15,789	16,482	16,421	15,347	-1,254	16,676	16,188	17,185	15,961
Net Nonoperating Expense (NNE)	-857	902	20	21	21	21	23	25	25	29
Net Nonoperating Obligations (NNO)	-15,896	-16,483	-17,236	-17,035	-16,163	-17,432	-18,115	-17,785	-18,388	-17,267
Total Depreciation and Amortization (D&A)	88	90	92	94	96	98	99	102	104	104
Debt-free, Cash-free Net Working Capital to Revenue	-16.50%	-13.99%	-14.04%	-14.55%	-14.27%	-15.99%	-21.21%	-21.80%	-21.52%	-22.47%
Debt-free Net Working Capital to Revenue	-5.78%	310.68%	324.02%	315.89%	245.01%	-14.09%	314.13%	297.78%	307.68%	283.43%
Net Working Capital to Revenue	-16.36%	302.08%	314.21%	311.00%	238.07%	-23.02%	300.89%	286.20%	300.04%	276.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.92	$2.50	$2.32	$2.26	$2.72	$2.91	$2.71	$2.83	$3.45	$3.00
Adjusted Weighted Average Basic Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M
Adjusted Diluted Earnings per Share	$1.90	$2.47	$2.28	$2.24	$2.68	$2.87	$2.67	$2.83	$3.44	$3.00
Adjusted Weighted Average Diluted Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.27M	96.50M	95.55M	94.82M	94.12M	93.71M	92.27M	89.82M	83.95M	83.85M
Normalized Net Operating Profit after Tax (NOPAT)	-666	1,144	244	236	278	296	277	284	328	284
Normalized NOPAT Margin	-305.61%	47.38%	18.46%	17.81%	20.09%	20.89%	19.58%	19.69%	22.55%	19.39%
Pre Tax Income Margin	107.72%	12.29%	20.75%	19.94%	23.03%	23.78%	22.24%	22.38%	25.90%	21.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.80	56.80	12.03	11.25	13.28	14.11	12.00	11.26	13.01	9.76
NOPAT to Interest Expense	-27.79	46.39	9.81	9.15	10.71	11.52	9.69	9.03	10.46	7.97
EBIT Less CapEx to Interest Expense	10.54	56.47	11.70	10.57	12.87	13.60	11.69	10.70	12.08	9.34
NOPAT Less CapEx to Interest Expense	-28.05	46.06	9.48	8.48	10.29	11.01	9.37	8.47	9.52	7.55
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	9.69%	9.01%	9.19%	9.40%	8.85%	8.67%	8.50%	8.26%	7.93%	7.98%
Augmented Payout Ratio	67.94%	59.84%	67.62%	62.19%	60.55%	61.31%	43.99%	65.84%	108.41%	101.57%

Frequently Asked Questions About Globe Life's Financials

When does Globe Life's fiscal year end?

According to the most recent income statement we have on file, Globe Life's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Globe Life's net income changed over the last 9 years?

Globe Life's net income appears to be on an upward trend, with a most recent value of $1.07 billion in 2024, rising from $527.10 million in 2015. The previous period was $970.76 million in 2023.

What is Globe Life's operating income?

Globe Life's total operating income in 2024 was $1.45 billion, based on the following breakdown:

Total Gross Profit: $2.88 billion
Total Operating Expenses: $1.43 billion

How has Globe Life revenue changed over the last 9 years?

Over the last 9 years, Globe Life's total revenue changed from $3.77 billion in 2015 to $5.78 billion in 2024, a change of 53.4%.

How much debt does Globe Life have?

Globe Life's total liabilities were at $23.77 billion at the end of 2024, a 0.9% increase from 2023, and a 50.5% increase since 2015.

How much cash does Globe Life have?

In the past 9 years, Globe Life's cash and equivalents has ranged from $61.38 million in 2015 to $165.33 million in 2024, and is currently $165.33 million as of their latest financial filing in 2024.

How has Globe Life's book value per share changed over the last 9 years?

Over the last 9 years, Globe Life's book value per share changed from 32.88 in 2015 to 63.20 in 2024, a change of 92.2%.

Remove Ads

Related Companies

This page (NYSE:GL) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Globe Life (GL) Financials

Frequently Asked Questions About Globe Life's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Globe Life (GL) Financials

Annual Income Statements for Globe Life

Quarterly Income Statements for Globe Life

Annual Cash Flow Statements for Globe Life

Quarterly Cash Flow Statements for Globe Life

Annual Balance Sheets for Globe Life

Quarterly Balance Sheets for Globe Life

Annual Metrics and Ratios for Globe Life

Quarterly Metrics and Ratios for Globe Life

Frequently Asked Questions About Globe Life's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools